BlackLeafwatch the watchmen
Medicare Prior Authorization

Original Medicare gets prior authorization — and the reviewers get a cut of what they deny

Summary

Starting January 2026, CMS is paying outside contractors a share of the Medicare spending they block on six services in six states, aimed at care MedPAC estimates cost the program up to $5.8 billion in 2022. The tool already costs practices 13 hours a week everywhere private insurers use it.

By Vindex · July 10, 2026

For sixty years, Original Medicare paid the claim first and asked questions later. Private Medicare Advantage plans have required prior authorization — a doctor's request for permission before Medicare will pay — for years. Traditional, fee-for-service Medicare never had. On January 1, 2026, that changed. Under a six-year pilot called WISeR ("Wasteful and Inappropriate Service Reduction"), hired outside technology companies to screen claims for a short list of services in six states before paying them — and is paying those companies a cut of every dollar they keep the program from spending.

MedPAC low-value care estimate, 2022
$5.8B
as low as $1.9B under a narrower measure
Beneficiaries in the 6 pilot states, 2024
207,500
of 1.1M nationwide who used a listed service
Physician + staff time on prior auth
13 hrs/wk
40% of practices staff someone full time

The target: waste says it can measure

didn't invent the $1.9–$5.8 billion figure it uses to justify WISeR — it borrowed it from the Medicare Payment Advisory Commission (MedPAC), the independent body that advises Congress on Medicare payment. Applying 31 clinical measures of "low-value care" — services with little or no proven benefit to the patient who received them — to a full year of fee-for-service claims, MedPAC's July 2024 Data Book found that in 2022, Medicare spent between $1.9 billion (its narrower measure, 34 low-value services per 100 beneficiaries) and $5.8 billion (its broader measure, 71 services per 100 beneficiaries) on procedures that mostly shouldn't have happened.

MedPAC's estimate of low-value care spending in Original Medicare
Two measures of the same 2022 fee-for-service claims data
Narrower measure
$1.9B
Broader measure
$5.8B
Source: MedPAC, Health Care Spending and the Medicare Program: A Data Book, July 2024, Chart 7-12
View data as table
Low-value care spending estimate by measure, 2022
Narrower measure$1.9B34 services / 100 beneficiaries
Broader measure$5.8B71 services / 100 beneficiaries

WISeR doesn't chase all of that spending. narrowed the pilot to a short list of services — including knee arthroscopy, electrical nerve stimulators, and skin and tissue substitutes used on wounds like diabetic foot ulcers — chosen because they have "prior reports of fraud, waste and abuse," according to CMS's own model factsheet.

Why skin substitutes made the list

One category shows why. KFF's analysis of CMS traditional Medicare claims found that the average Medicare payment for a single skin-substitute application rose 820% between 2019 and 2024 — from $2,300 to $21,200 — the largest price increase of any WISeR-listed service category over that period.

Average Medicare payment per skin-substitute application
Traditional Medicare claims, 2019 vs. 2024
2019 (avg. payment/service)
$2,300
2024 (avg. payment/service)
$21,200
Source: KFF analysis of CMS traditional Medicare claims data, Feb. 2026
View data as table
Average payment per service, 2019 vs. 2024
2019 avg. payment per service$2,300
2024 avg. payment per service$21,200+820%

That kind of run-up — in a product category, not a patient population — is exactly the pattern a prior-authorization screen is built to catch. But the number of Medicare patients it will touch is small relative to the program: found that only about 1.1 million traditional Medicare beneficiaries nationwide (3.2% of everyone in fee-for-service Medicare) received a WISeR-listed service at all in 2024, and just 207,500 of them — 19.7% — lived in one of the six pilot states where the new review actually applies starting this year.

Who WISeR actually touches
Traditional Medicare beneficiaries who used a listed service, 2024
Orthopedic pain mgmt. (nationwide)
908,000
Skin substitutes (nationwide)
98,000
Located in the 6 pilot states
207,500
Source: KFF analysis of CMS traditional Medicare claims data, Feb. 2026
View data as table
Beneficiaries by service category and pilot-state residence
Orthopedic pain management (nationwide)908,00086% of users
Skin substitutes (nationwide)98,0009.3% of users
In the 6 pilot states207,50019.7% of the 1.1M national total

Of the 1.1 million nationwide, 86% (908,000) got some form of orthopedic pain management — knee arthroscopy, nerve stimulator implants, and similar procedures for conditions like osteoarthritis — and just 9.3% (98,000) got skin substitutes, the category with the steepest price increase.

The incentive: paid by the denial

The mechanism that makes WISeR different from ordinary Medicare auditing is how its contractors get paid. Under CMS's Request for Applications, model participants don't receive a flat contract fee — they "receive a percentage of the reduction in expenditures, or savings, that can be directly attributed to" their prior-authorization reviews. In plain terms: when a company's AI-and-clinician review team turns down a claim and it stays turned down, pays that company a cut of what Medicare didn't have to spend. has not published the exact percentage. It has built in some counterweight — a "baseline denial rate" discount so contractors aren't credited for denials a human Medicare contractor would have made anyway, an annual quality-score adjustment that can shrink payments for poor performance, and a clawback if a denied claim is later approved on appeal — but the core structure still ties a company's revenue to how much it says no.

Providers aren't without recourse. Per CMS's WISeR FAQ, participants must return most decisions within 72 hours, a denied request can be resubmitted an unlimited number of times, and says it plans to launch a "gold carding" exemption sometime in 2026 for providers with a track record of clean requests. Coverage and payment rules themselves don't change — WISeR only adds a review step before payment.

The context Medicare didn't have before

Original Medicare is adopting a tool that every other part of the health system already uses — and the American Medical Association's 2025 Prior Authorization Physician Survey is the clearest record of what that tool costs where it already runs. Surveying 1,000 physicians nationwide, AMA found that practices complete an average of 40 prior authorization requests per physician per week, and that physicians and their staff spend 13 hours a week completing them. Two in five physicians (40%) employ staff who work exclusively on prior authorization. Nearly a third (32%) say authorizations are "often" or "always" denied, and 74% say denials have increased over the past five years. More than a quarter (26%) report that prior authorization has led to a serious adverse event for one of their patients.

None of that survey data is specific to WISeR — it describes prior authorization as practiced today by commercial insurers and Medicare Advantage plans, not the six-state Original Medicare pilot, which is too new to have its own denial or appeal statistics yet. It's the baseline WISeR is stepping into.

The takeaway

  • The dollar case is real but narrow. MedPAC's own numbers put low-value Medicare spending at up to $5.8 billion in 2022 — but WISeR's list of covered services, states, and roughly 207,500 exposed beneficiaries covers a small slice of that.
  • The payment design creates a direct financial interest in denial. Contractors are paid a share of what they keep Medicare from spending — has added safeguards (a baseline-denial discount, quality scoring, appeal clawbacks) but hasn't published what percentage contractors actually keep.
  • The best data on what this looks like in practice comes from everywhere else. AMA's national survey — 13 hours a week, 40% staffing burden, a quarter of physicians reporting a serious adverse event tied to prior authorization — describes the system Original Medicare is now testing on itself, not WISeR directly.

WISeR launched January 2026 in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington; figures on beneficiaries, spending, and prices above are drawn from 2022–2024 data, the most recent available before the model's design was finalized, and will be superseded as publishes its own model-specific results.

Sources

Weekly digest: the most-read systems, in brief. Mondays.

Comments

Always open. Logged-in readers can annotate paragraphs in place.

Loading comments…
or log in to comment under your account